Alterity Therapeutics (ATHE) Rent Expense (2015 - 2025)
Alterity Therapeutics (ATHE) recorded quarterly Rent Expense of $9656.9 in Q4 2025, up 52.96% quarter-over-quarter from $6313.3 in Q4 2024, and up 52.96% on a YoY basis from $6313.3 in Q4 2024.
Alterity Therapeutics (ATHE) Rent Expense (2015 - 2025) Analysis & Trends
Alterity Therapeutics' Rent Expense history runs 10 years deep, the most recent figure standing at $9656.9 for Q4 2025.
- In Q4 2025, Rent Expense rose 52.96% year-over-year to $9656.9; the TTM figure through Dec 2025 stood at $37419.3 (down 25.09% YoY), while the FY2024 annual figure was -$6.4 billion, down 113.9% from the prior year.
- Rent Expense was $9656.9 for Q4 2025 at Alterity Therapeutics, up from $6313.3 in the prior quarter.
- In the past five years, Rent Expense ranged from a high of $24488.5 in Q4 2022 to a low of -$3039.5 in Q4 2023.
- Historically, Rent Expense has averaged $11921.6 across 5 years, with a median of $9656.9 in 2025.
- The sharpest annual moves came in 2023 and 2024: Rent Expense slumped 112.41% in 2023, then soared 307.71% in 2024.
- A 5-year view of Rent Expense shows it stood at $22188.7 in 2021, then climbed by 10.36% to $24488.5 in 2022, then plunged by 112.41% to -$3039.5 in 2023, then jumped by 307.71% to $6313.3 in 2024, then soared by 52.96% to $9656.9 in 2025.
- The last three Rent Expense figures came in at $9656.9 (Q4 2025), $6313.3 (Q4 2024), and -$3039.5 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Rental Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 9,656.91 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,656.91 |
| Dec 31, 2025 | 9,656.91 |
| Dec 31, 2024 | 6,313.30 |
| Dec 31, 2024 | 6,313.30 |
| Dec 31, 2023 | -3,039.47 |
| Dec 31, 2023 | -3,039.47 |
| Dec 31, 2022 | 24,488.52 |
| Dec 31, 2022 | 24,488.52 |
| Dec 31, 2021 | 22,188.68 |
| Dec 31, 2021 | 22,188.68 |
| Dec 31, 2019 | 20,712.24 |
| Dec 31, 2019 | 20,712.24 |
| Dec 31, 2018 | 52,902.97 |
| Dec 31, 2018 | 52,902.97 |
| Dec 31, 2017 | 68,141.43 |
| Dec 31, 2017 | 68,141.43 |
| Dec 31, 2016 | 74,378.20 |
| Dec 31, 2016 | 74,378.20 |
| Dec 31, 2015 | 161,175.00 |
| Dec 31, 2015 | 161,175.00 |